GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » COGS-to-Revenue

Sun Pharmaceuticals Industries (BOM:524715) COGS-to-Revenue : 0.21 (As of Mar. 2025)


View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries COGS-to-Revenue?

Sun Pharmaceuticals Industries's Cost of Goods Sold for the three months ended in Mar. 2025 was ₹26,372 Mil. Its Revenue for the three months ended in Mar. 2025 was ₹128,156 Mil.

Sun Pharmaceuticals Industries's COGS to Revenue for the three months ended in Mar. 2025 was 0.21.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sun Pharmaceuticals Industries's Gross Margin % for the three months ended in Mar. 2025 was 79.42%.

Sun Pharmaceuticals Industries COGS-to-Revenue Historical Data

The historical data trend for Sun Pharmaceuticals Industries's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries COGS-to-Revenue Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.27 0.28 0.22 0.21

Sun Pharmaceuticals Industries Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.21 0.20 0.20 0.21

Sun Pharmaceuticals Industries COGS-to-Revenue Calculation

Sun Pharmaceuticals Industries's COGS to Revenue for the fiscal year that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=107473.6 / 520412.5
=0.21

Sun Pharmaceuticals Industries's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=26371.9 / 128155.8
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries  (BOM:524715) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sun Pharmaceuticals Industries's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 26371.9 / 128155.8
=79.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sun Pharmaceuticals Industries COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » COGS-to-Revenue
Comparable Companies
NSE:DIVISLAB BOM:500087 NSE:TORNTPHARM BOM:500124 BOM:543904 BOM:532321 BOM:500257 NSE:AUROPHARMA BOM:500488 NSE:ALKEM ZTS XTER:MRK LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ HKSE:03692 XTAE:TEVA SHSE:688506 SZSE:000538
Traded in Other Exchanges
SUNPHARMA:India
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Website
https://www.sunpharma.com
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.

Sun Pharmaceuticals Industries Headlines

No Headlines